Drugs and the liver: Advances in metabolism, toxicity, and therapeutics

Current Opinion in Pediatrics

Volumn 14, Issue 5, 2002, Pages 601-607

  Buratti, Silvia ^a   Lavine, Joel E ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLCYSTEINE; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDOTE; ANTINEOPLASTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARNITINE; CISAPRIDE; CLINDAMYCIN; CYCLOSPORIN; CYTOCHROME P450 3A4; DIGOXIN; DRUG METABOLIZING ENZYME; HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; LIVER ENZYME; MIDAZOLAM; NAFCILLIN; OXACILLIN; PEMOLINE; RIFAMPICIN; THEOPHYLLINE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; WARFARIN;

ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; GENETIC POLYMORPHISM; HUMAN; LIVER DEVELOPMENT; LIVER PARENCHYMA; LIVER TOXICITY; NONHUMAN; PHARMACOGENETICS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PUBERTY; REVIEW;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY; DRUG TOXICITY; HUMANS; INFANT; INFANT, NEWBORN; LIVER; LIVER DISEASES; PHARMACEUTICAL PREPARATIONS;

EID: 0036785453     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200210000-00007     Document Type: Review

References (45)

1. Cytochromes P450 and metabolism of xenobiotics
2. The ontogeny of human drug-metabolizing enzymes: Phase I oxidative enzymes
3. The ontogeny of human drug-metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms
4. Evidence of impaired cisapride metabolism in neonates
5. Developmental aspects of human hepatic drug glucuronidation in young children and adults
6. Neonatal drug elimination
7. Pharmacokinetic and other drug interactions in patients with AIDS
8. Interactions between herbal medicines and prescribed drugs: A systematic review
9. St John's Wort supplements endanger the success of organ transplantation
10. Oral midazolam-grapefruit juice drug interaction
11. Inter individual variability in acetaminophen glucuronidation by human liver microsomes: Identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms
12. Increased risk of antitubercolosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation
13. Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression
14. Drug-induced liver disease
15. Mechanisms of hepatotoxicity
16. Aspirin-related hepatotoxicity in a child after liver transplant
17. Interstitial nephritis, hepatic failure, and systemic eosinophilia after minocycline treatment
18. Possible roxithromycin fulminant hepatic failure in a child
19. Severe hepatic injury associated with lipid formulations of amphotericin B
20. Progressive elevation of liver enzymes in a child treated with sulthiame
21. Hepatocellular injury following the administration of propofol
22. Veno-occlusive disease with multi-organ involvement following actinomycin-D
23. Higher occurrence of hepatotoxicity and rash in patients treated with oxacillin, compared with those treated with nafcillin and other commonly used antimicrobials
24. Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease
25. Antiepileptic hypersensitivity syndrome in children
26. Pemoline hepatotoxicity and post-marketing surveillance
27. 2-receptor antagonists
28. Hepatotoxicity of chemotherapy
29. Herbal treatment in gastrointestinal and liver disease-benefits and dangers
30. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
31. Effect of L-carnitine treatment for valproate-induced hepatotoxicity
32. Nucleoside analogues for chronic hepatitis B
33. Lamivudine and interferon-alpha combination treatment of childhood patients with chronic hepatitis B infection
34. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen
35. Antiviral L-nucleosides specific for hepatitis B virus infection
36. Peginterferon-alpha-2a (40kD): A review of its use in the management of chronic hepatitis C
37. Current and novel immunosuppressive therapy for autoimmune hepatitis
38. Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis
39. Metformin reverses fatty liver disease in obese, leptin deficient mice
40. Metformin in nonalcoholic steatohepatitis
41. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: Results of a pilot study
42. Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
43. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus